Consejo Nacional de Salud

Referencias bibliográficas
Agentes antineoplásicos e inmunomoduladores
1 Dann E J, Bar-Shalom R, Tamir A, Haim N, Ben-
Shachar M, Avivi I, Zuckerman T, Kirschbaum M,
Goor O, Libster D, Rowe J M, Epelbaum R, Riskadapted
BEACOPP regimen can reduce the cumulative
dose of chemotherapy for standard and
high-risk Hodgkin lymphoma with no impairment
of outcome, BLOOD, 1 February 2007 _ Volume
109, Number 3 From Www.Bloodjournal.Org By
On November 19, 2008.
2 Micallef I N M, Kahl B S, Maurer MJ, Dogan
A, Ansell S M, Colgan J P, Geyer S, Inwards D
J, White W L, Habermann T M, A Pilot Study of
Epratuzumab and Rituximab in Combination With
Cyclophosphamide, Doxorubicin, Vincristine, and
Prednisone Chemotherapy in Patients With Previously
Untreated, Diffuse Large B-Cell Lymphoma,
CANCER December 15, 2006 / Volume 107 /
Number 12, 2828-32
3 Shin H-J, Chung J S, Lee J J, Sohn S K, Jin Choi Y,
Kim J-K, Yang D-H, Kim H-J, Kim J-G, Don Joo Y,
Lee W S, Sohn Ch, Lee E Y, Cho G J, Treatment
Outcomes with CHOP Chemotherapy in Adult Patients
with Hemophagocytic Lymphohistiocytosis,
J Korean Med Sci 2008; 23: 439-44
4 Hodson EM, Willis NS, Craig JC. Non-corticosteroid
treatment for nephrotic syndrome in
children. Cochrane Database of Systematic Reviews
2008, Issue 1. Art. No.: CD002290. DOI:
10.1002/14651858.CD002290.pub3.
5 Flanc RS, Roberts MA, Strippoli GFM, Chadban
SJ, Kerr PG, Atkins RC. Treatment for lupus
nephritis. Cochrane Database of Systematic Reviews
2004, Issue 1. Art. No.: CD002922. DOI:
10.1002/14651858.CD002922.pub2.
6 Schieppati A, Perna A, Zamora J, Giuliano GA,
Braun N, Remuzzi G. Immunosuppressive treatment
for idiopathic membranous nephropathy
in adults with nephrotic syndrome. Cochrane
Database of Systematic Reviews 2004, Issue 4.
Art. No.: CD004293. DOI: 10.1002/14651858.
CD004293.pub2.
7 Metayer, C. Myelodysplastic syndrome and acute
myeloid leukemia after autotransplantation for
lymphoma. [Texas]: Blood, 2003. Disponible en
WWW: http://bloodjournal.hematologylibrary.
org/cgi/content/101/5/2015 [Consulta: 13, Noviembre
2008].
8 Barey, O. Non-Hodgkin's lymphoma in patients
80 years of age or older. [Israel]: Annals oncology,
2006. Disponible en WWW: http://annonc.
oxfordjournals.org/cgi/content/full/17/6/928
[Consulta: 10, noviembre 2008].
9 Steurer M, Pall G, Richards S, Schwarzer G, Bohlius
J, Greil R. Antagonistas de purinas para la
leucemia linfocítica crónica (Revisión Cochrane
traducida). En: La Biblioteca Cochrane Plus,
2008 Número 2. Oxford: Update Software Ltd.
Disponible en: http://www.update-software.com
. (Traducida de The Cochrane Library, 2008 Issue
2. Chichester, UK: John Wiley & Sons, Ltd.).
10 San Miguel J, Schlag R, Khuageva N K, Dimopoulos
M A, Shpilberg O, Kropff M, Spicka I, Petrucci
M T, Palumbo A, Samoilova O S, Dmoszynska A,
Kudrat D, Schots R, Jiang, B, M-V Mateos, Anderson
K C, Esseltine D, Liu L, Cakana A, van de Velde
H, Richardson P, Bortezomib plus Melphalan
and Prednisone for Initial Treatment of Multiple
Myeloma, N Engl J Med 2008;359:906-17.
GRUPO L | Agentes antineoplásicos e inmunomoduladores
389
L